
Maypharm
Pine Bottle Lipolysis
Brand
Maypharm
Category
Lipolysis
Origin
Korea
Interested in ordering Pine Bottle Lipolysis? Send an enquiry and our team will follow up with availability and pricing.
Used in
Overview
Pine Bottle is a Korean injectable lipolysis solution formulated deliberately without deoxycholic acid (DC) or phosphatidylcholine (PPC), instead relying on an enzyme- and vitamin-based trio. It is positioned as a gentler alternative for face and body contouring with a lower swelling profile than classic bile-acid formulas. Supplied as 10 ml x 5 vials for staged, progressive treatment.
How it works
In place of the bile-acid pathway, lecithin emulsifies and helps break down stored triglycerides within the subcutaneous fat layer while bromelain acts as an anti-inflammatory proteolytic enzyme and riboflavin supports fat metabolism and cellular energy. Liberated lipids are mobilised and cleared through the lymphatic and vascular circulation. Because it is DC/PPC-free, membrane-disruptive irritation and post-injection swelling tend to be more manageable than with deoxycholate-based products.
Indications
- Submental fat / double chin
- Jawline and lower-face contouring
- Abdominal localised fat
- Thighs and arms
- Non-surgical body slimming
Key features
- DC/PPC-free enzyme-and-vitamin lipolysis formula
- Lecithin, bromelain and riboflavin actives
- Lower swelling profile than bile-acid solutions
- Suitable for both facial and body areas
- Supplied 10 ml x 5 vials for staged protocols
Benefits
- Gentler adverse-event profile supports patient tolerability and retention
- Versatile across face and body indications from a single SKU
- Predictable staged protocol aids scheduling and repeat visits
- Positioned as a differentiated non-bile-acid option in the lipolysis category
- Convenient multi-vial packaging for clinic inventory
Composition
Lecithin, Bromelain (pineapple / Ananas sativus fruit extract), Riboflavin (Vitamin B2). Free of deoxycholic acid and phosphatidylcholine (DC/PPC-free).
Usage & handling
For clinician use only. Administer as multiple small subcutaneous deposits across a grid pattern within the target fat pad using conservative per-point volumes; avoid intramuscular or intradermal placement. Localised swelling, tenderness and bruising are expected and should be counselled in advance. Stage treatment across sessions (approximately 4-week intervals) rather than over-treating in a single visit. Maintain awareness of regional nerve and vascular anatomy, particularly the marginal mandibular nerve when treating the jawline and submental region.
For medical professionals. Product information is for reference and does not replace the manufacturer's instructions for use. Availability and regulatory status vary by region.